Financials Techno Medica Co., Ltd.

Equities

6678

JP3545110003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 11:30:00 02/05/2024 am IST 5-day change 1st Jan Change
1,730 JPY +0.17% Intraday chart for Techno Medica Co., Ltd. +0.29% -21.79%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 17,504 18,107 16,135 14,241 13,303 15,974
Enterprise Value (EV) 1 8,177 8,589 6,373 4,103 1,780 4,224
P/E ratio 13.4 x 16.4 x 15.9 x 12.2 x 10.4 x 13.9 x
Yield - - - - - -
Capitalization / Revenue 2.02 x 1.94 x 1.64 x 1.58 x 1.37 x 1.71 x
EV / Revenue 0.94 x 0.92 x 0.65 x 0.45 x 0.18 x 0.45 x
EV / EBITDA 4.72 x 5.41 x 4.71 x 2.37 x 0.91 x 2.4 x
EV / FCF 6.02 x 13 x 9.7 x 6.15 x 0.98 x 7.38 x
FCF Yield 16.6% 7.69% 10.3% 16.3% 102% 13.6%
Price to Book 1.34 x 1.31 x 1.12 x 0.94 x 0.84 x 0.98 x
Nbr of stocks (in thousands) 8,610 8,610 8,610 8,610 8,522 8,430
Reference price 2 2,033 2,103 1,874 1,654 1,561 1,895
Announcement Date 27/06/18 26/06/19 25/06/20 25/06/21 28/06/22 28/06/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 8,654 9,332 9,810 9,040 9,699 9,367
EBITDA 1 1,734 1,588 1,352 1,728 1,957 1,757
EBIT 1 1,663 1,518 1,258 1,608 1,837 1,649
Operating Margin 19.22% 16.27% 12.82% 17.79% 18.94% 17.6%
Earnings before Tax (EBT) 1 1,670 1,549 1,338 1,649 1,850 1,665
Net income 1 1,308 1,098 1,000 1,153 1,281 1,150
Net margin 15.11% 11.77% 10.19% 12.75% 13.21% 12.28%
EPS 2 152.0 128.1 117.8 135.7 150.8 136.3
Free Cash Flow 1 1,358 660.8 657.2 667 1,817 572.6
FCF margin 15.7% 7.08% 6.7% 7.38% 18.74% 6.11%
FCF Conversion (EBITDA) 78.34% 41.61% 48.61% 38.6% 92.85% 32.59%
FCF Conversion (Net income) 103.85% 60.18% 65.72% 57.85% 141.85% 49.79%
Dividend per Share - - - - - -
Announcement Date 27/06/18 26/06/19 25/06/20 25/06/21 28/06/22 28/06/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 4,704 3,701 4,291 2,117 1,786 3,772 2,289 1,770 4,056 2,368
EBITDA - - - - - - - - - -
EBIT 1 605 404 669 305 121 446 377 81 523 405
Operating Margin 12.86% 10.92% 15.59% 14.41% 6.77% 11.82% 16.47% 4.58% 12.89% 17.1%
Earnings before Tax (EBT) 1 677 412 676 307 129 452 375 91 533 404
Net income 1 493 281 468 205 87 309 254 72 376 270
Net margin 10.48% 7.59% 10.91% 9.68% 4.87% 8.19% 11.1% 4.07% 9.27% 11.4%
EPS 2 58.08 33.21 54.96 24.10 10.37 36.71 30.19 8.750 46.16 33.88
Dividend per Share - - - - - - - - - -
Announcement Date 06/11/19 04/11/20 04/11/21 02/02/22 03/08/22 04/11/22 01/02/23 02/08/23 07/11/23 07/02/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 9,327 9,518 9,762 10,138 11,523 11,750
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 1,358 661 657 667 1,817 573
ROE (net income / shareholders' equity) 10.4% 8.21% 7.17% 7.92% 8.37% 7.18%
ROA (Net income/ Total Assets) 7.02% 6% 4.81% 5.89% 6.37% 5.43%
Assets 1 18,630 18,313 20,810 19,574 20,118 21,174
Book Value Per Share 2 1,515 1,603 1,669 1,756 1,855 1,934
Cash Flow per Share 2 1,086 1,110 1,151 1,190 1,366 1,387
Capex 1 53 73 423 30 66 133
Capex / Sales 0.61% 0.78% 4.31% 0.33% 0.68% 1.42%
Announcement Date 27/06/18 26/06/19 25/06/20 25/06/21 28/06/22 28/06/23
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 6678 Stock
  4. Financials Techno Medica Co., Ltd.